Registration

2009 2nd Quarter (Apr 1 - June 30) Foreign Entity
Income
—
Expenses
—
Official Senate LDA Document

Lobbying Activities

Licensing from NIH/OTT of existing drug compound for treatment of acute mental depression and post-traumatic stress disorder.
Lobbyists

Foreign Entities

QRXPHARMA LIMITED CAN
Country: Australia Contribution: $3,000 Ownership: 100.0%